International Patent: 4-((2-((7-AZABICYCLO[2.2.1]HEPTAN-7-YL)METHYL)-6-FLUOROBENZYL)AMINO)-2,3- DIFLUORO-N-(THIAZOL- 4-YL)BENZENESULFONAMIDE FOR USE IN TREATING EPILEPTIC DISORDERS

GENEVA, Aug. 7 -- NEUROCRINE BIOSCIENCES, INC. filed a patent application (US2026/013255) for “4-((2-((7-AZABICYCLO[2.2.1]HEPTAN-7-YL)METHYL)-6-FLUOROBENZYL)AMINO)-2,3- DIFLUORO-N-(THIAZOL- 4-YL)BENZENESULFONAMIDE FOR USE IN TREATING EPILEPTIC DISORDERS”. With publication no. WO/2026/165348, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/55

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....